A Comparative Study of the Global Burden of Prostate Cancer (1990–2021): Emphasis on the Disparities Between the United States and China
The PCa burden in the US and China has evolved in markedly different directions over the past three decades, reflecting profound impact in screening strategies and population aging. High SDI countries should refine risk-based screening protocols and management strategies. Meanwhile, China and other low and middle SDI countries must expand early, targeted screening for high-risk populations and strengthen primary healthcare to mitigate the growing burden.
Authors
- Junxiong Li (ORCID: https://orcid.org/0009-0009-6444-1060)
- Jian Hou (ORCID: https://orcid.org/0000-0002-2460-4904)
- Yumin Wang (ORCID: https://orcid.org/0000-0001-8243-3659)
- Feng Zhang (ORCID: https://orcid.org/0000-0001-7566-1477)
- Haolin Liu (ORCID: https://orcid.org/0009-0002-5583-2974)
- Yupeng Wu (ORCID: https://orcid.org/0000-0003-4451-9739)
- Peng Gu (ORCID: https://orcid.org/0000-0002-9646-172X)
- Xiaodong Liu (ORCID: https://orcid.org/0009-0008-8609-9983)
Institutions
- Sichuan University (CN)
- Kunming Medical University (CN)
- West China Hospital of Sichuan University (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
- 421 Hospital of PLA (CN)
Publication Details
- Journal
- The Prostate
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1002/pros.70104
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52